Zhu X, Wei Y, Yang Q et al (2023) FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia[J]. J Hematol Oncol 16(1):9

Watts JM, Bradley T (2020) The Hi’s and Lo’s of cytarabine in acute myeloid leukemia[J]. Clin Cancer Res 26(13):3073–3076

Article  CAS  PubMed  PubMed Central  Google Scholar 

Momparler RL (2013) Optimization of cytarabine (ARA-C) therapy for acute myeloid leukemia[J]. Exp Hematol Oncol 2(1):20

Article  PubMed  PubMed Central  Google Scholar 

Song Y, Park SY, Wu Z et al (2020) Hybrid inhibitors of DNA and HDACs remarkably enhance cytotoxicity in leukaemia cells[J]. J Enzyme Inhib Med Chem 35(1):1069–1079

Article  CAS  PubMed  PubMed Central  Google Scholar 

Heuser M, Ofran Y, Boissel N et al (2020) Acute myeloid leukaemia in adult patients: ESMO clinical practice guidelines for diagnosis, treatment and follow-up[J]. Ann Oncol 31(6):697–712

Article  CAS  PubMed  Google Scholar 

Malani D, Murumägi A, Yadav B et al (2017) Enhanced sensitivity to glucocorticoids in cytarabine-resistant AML[J]. Leukemia 31(5):1187–1195

Article  CAS  PubMed  Google Scholar 

Li Z, Guo J, Chen Q et al (2017) Exploring the antitumor mechanism of high-dose cytarabine through the metabolic perturbations of ribonucleotide and deoxyribonucleotide in human promyelocytic leukemia HL-60 cells[J]. Molecules 22(3):499

Article  PubMed  PubMed Central  Google Scholar 

Pollyea DA, Bixby D, Perl A et al (2021) (2021) NCCN guidelines insights: acute myeloid leukemia, version 2.2021[J]. J Natl Compr Canc Netw 19(1):16–27

Article  PubMed  Google Scholar 

DiNardo C, Lachowiez C (2019) Acute myeloid leukemia: from mutation profiling to treatment decisions[J]. Curr Hematol Malig Rep 14(5):386–394

Article  PubMed  Google Scholar 

Rausch C, Rothenberg-Thurley M, Dufour A et al (2023) Validation and refinement of the 2022 European LeukemiaNet genetic risk stratification of acute myeloid leukemia[J]. Leukemia 37(6):1234–1244

Article  CAS  PubMed  PubMed Central  Google Scholar 

Menendez-Gonzalez JB, Sinnadurai S, Gibbs A et al (2013) Inhibition of GATA2 restrains cell proliferation and enhances apoptosis and chemotherapy mediated apoptosis in human GATA2 overexpressing AML cells[J]. Sci Rep 9(1):12212

Li Y, Yuan S, Liu J et al (2020) CSE1L silence inhibits the growth and metastasis in gastric cancer by repressing GPNMB via positively regulating transcription factor MITF[J]. J Cell Physiol 235(3):2071–2079

Article  CAS  PubMed  Google Scholar 

Pimiento JM, Neill KG, Henderson-Jackson E et al (2016) Knockdown of CSE1L gene in colorectal cancer reduces tumorigenesis in vitro[J]. Am J Pathol 186(10):2761–2768

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu W, Zhou Z, Li Y et al (2021) CSE1L silencing impairs tumor progression via MET/STAT3/PD-L1 signaling in lung cancer[J]. Am J Cancer Res 11(9):4380–4393

CAS  PubMed  PubMed Central  Google Scholar 

Liu C, Wei J, Xu K et al (2019) CSE1L participates in regulating cell mitosis in human seminoma[J]. Cell Prolif 52(2):e12549

Nagashima S, Maruyama J, Honda K et al (2021) CSE1L promotes nuclear accumulation of transcriptional coactivator TAZ and enhances invasiveness of human cancer cells[J]. J Biol Chem 297(1):100803

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lin H C, Li J, Cheng D et al (2021) Nuclear export protein CSE1L interacts with P65 and promotes NSCLC growth via NF-κB/MAPK pathway[J]. Molec Ther – Oncol 21(prepublish):23–36

Chang CC, Kao WY, Liu CY et al (2022) Butyrate supplementation regulates expression of chromosome segregation 1‑like protein to reverse the genetic distortion caused by p53 mutations in colorectal cancer[J]. Int J Oncol 60(6):64

Hu J, Qiu D, Yu A et al (2021) YTHDF1 Is a potential pan-cancer biomarker for prognosis and immunotherapy[J]. Front Oncol 11:607224

Lu K, Li B, Zhang H et al (2020) A novel silicone derivative of natural osalmid (DCZ0858) induces apoptosis and cell cycle arrest in diffuse large B-cell lymphoma via the JAK2/STAT3 pathway[J]. Signal Trans Target Ther 5(1):31

Article  CAS  Google Scholar 

Behrens P, Brinkmann U, Wellmann A (2003) CSE1L/CAS: Its role in proliferation and apoptosis[J]. Apoptosis (London) 8(1):39–44

Article  CAS  Google Scholar 

Luo Y, Qu X, Kan D et al (2021) The microRNA-451a/chromosome segregation 1-like axis suppresses cell proliferation, migration, and invasion and induces apoptosis in nasopharyngeal carcinoma[J]. Bioengineered 12(1):6967–6980

Article  CAS  PubMed  PubMed Central  Google Scholar 

Paech F, Abegg VF, Duthaler U et al (2018) Sunitinib induces hepatocyte mitochondrial damage and apoptosis in mice[J]. Toxicology 409:13–23

Article  CAS  PubMed  Google Scholar 

Dethlefsen MM, Halling JF, Moller HD et al (2018) Regulation of apoptosis and autophagy in mouse and human skeletal muscle with aging and lifelong exercise training[J]. Exp Gerontol 111:141–153

Article  PubMed  Google Scholar 

Lin K, Zhao W, Huang S et al (2021) Grape seed proanthocyanidin extract induces apoptosis of HL-60/ADR cells via the Bax/Bcl-2 caspase-3/9 signaling pathway[J]. Translational Cancer Research 10(9):3939–3947

Article  CAS  PubMed  PubMed Central  Google Scholar 

Man N, Tan Y, Sun X et al (2017) Caspase-3 controls AML1-ETO–driven leukemogenesis via autophagy modulation in a ULK1-dependent manner[J]. Blood 129(20):2782–2792

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xue F, Zhu Y, Xu F et al (2019) MicroRNA-199 inhibits proliferation and promotes apoptosis in children with acute myeloid leukemia by mediating caspase-3.[J]. Europ Rev Med Pharmacol Sci 23(9):3584–3593

CAS  Google Scholar 

Fajardo-Orduña GR, Ledesma-Martínez E, Aguiñiga-Sánchez I et al (2021) Inhibitors of chemoresistance pathways in combination with ara-c to overcome multidrug resistance in AML. A mini review[J]. Int J Molec Sci 22(9):4955

Article  Google Scholar 

Shang Q, Pan C, Zhang X et al (2023) Nuclear factor Nrf2 promotes glycosidase OGG1 expression by activating the AKT pathway to enhance leukemia cell resistance to cytarabine[J]. J Biol Chem 299(1):102798

Article  CAS  PubMed  Google Scholar 

Zhang F, Sun J, Tang X et al (2022) Stabilization of SAMHD1 by NONO is crucial for Ara-C resistance in AML[J]. Cell Death Dis 13(7):511–590

Article  Google Scholar 

Lei B, Qian L, Zhang Y et al (2020) MLAA-34 knockdown shows enhanced antitumor activity via JAK2/STAT3 signaling pathway in acute monocytic leukemia[J]. J Cancer 11(23):6768–6781

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mesbahi Y, Zekri A, Ghaffari SH et al (2018) Blockade of JAK2/STAT3 intensifies the anti-tumor activity of arsenic trioxide in acute myeloid leukemia cells: novel synergistic mechanism via the mediation of reactive oxygen species[J]. Eur J Pharmacol 834:65–76

Article  CAS  PubMed  Google Scholar